Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 798

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived Cells

Open access
Galiano, Robert D., Tepper, Oren M., Pelo, Catherine R., Bhatt, Kirit A., Callaghan, Matthew, Bastidas, Nicholas, Bunting, Stuart, Steinmetz, Hope G., Gurtner, Geoffrey C.·2004·The American Journal of Pathology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)63754-6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 50

  1. Martin, 2003, Abnormal angiogenesis in diabetes mellitus, Med Res Rev, 23, 117, 10.1002/med.10024 · DOI · Paper page
  2. The Diabetes Control and Complications Trial Study Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
  3. Abaci, 1999, Effect of diabetes mellitus on formation of coronary collateral vessels, Circulation, 99, 2239, 10.1161/01.CIR.99.17.2239 · DOI · Paper page
  4. Beer, 1997, Reduced expression of PDGF and PDGF receptors during impaired wound healing, J Invest Dermatol, 109, 132, 10.1111/1523-1747.ep12319188 · DOI · Paper page
  5. Werner, 1994, Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse, J Invest Dermatol, 103, 469, 10.1111/1523-1747.ep12395564 · DOI · Paper page
  6. Bitar, 1996, Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing, J Surg Res, 61, 113, 10.1006/jsre.1996.0090 · DOI
  7. Brown, 1997, Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice, Am J Pathol, 151, 715
  8. Frank, 1995, Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing, J Biol Chem, 270, 12607, 10.1074/jbc.270.21.12607 · DOI · Paper page
  9. Carmeliet, 2000, Mechanisms of angiogenesis and arteriogenesis, Nat Med, 6, 389, 10.1038/74651 · DOI · Paper page
  10. Carmeliet, 1996, Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele, Nature, 380, 435, 10.1038/380435a0 · DOI · Paper page
  11. Gerber, 1999, VEGF is required for growth and survival in neonatal mice, Development, 126, 1149, 10.1242/dev.126.6.1149 · DOI · Paper page
  12. Lee, 2000, VEGF gene delivery to myocardium: deleterious effects of unregulated expression, Circulation, 102, 898, 10.1161/01.CIR.102.8.898 · DOI · Paper page
  13. Drake, 1995, Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization, Proc Natl Acad Sci USA, 92, 7657, 10.1073/pnas.92.17.7657 · DOI · Paper page
  14. Gill, 2001, Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells, Circ Res, 88, 167, 10.1161/01.RES.88.2.167 · DOI · Paper page
  15. Peichev, 2000, Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors, Blood, 95, 952, 10.1182/blood.V95.3.952.003k27_952_958 · DOI · Paper page
  16. Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat Med, 5, 434, 10.1038/8462 · DOI · Paper page
  17. Crosby, 2000, Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation, Circ Res, 87, 728, 10.1161/01.RES.87.9.728 · DOI · Paper page
  18. Asahara, 1999, VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells, EMBO J, 18, 3964, 10.1093/emboj/18.14.3964 · DOI · Paper page
  19. Tepper, 2002, Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures, Circulation, 106, 2781, 10.1161/01.CIR.0000039526.42991.93 · DOI · Paper page
  20. Tsuboi, 1992, A wound healing model using healing-impaired diabetic mice, J Dermatol, 19, 673, 10.1111/j.1346-8138.1992.tb03757.x · DOI
  21. Eppihimer, 1998, Differential expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) in murine tissues, Microcirculation, 5, 179, 10.1111/j.1549-8719.1998.tb00067.x · DOI
  22. Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85, 221, 10.1161/01.RES.85.3.221 · DOI · Paper page
  23. Hattori, 2001, Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells, J Exp Med, 193, 1005, 10.1084/jem.193.9.1005 · DOI · Paper page
  24. Nissen, 1998, Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing, Am J Pathol, 152, 1445
  25. Howdieshell, 1998, Normoxic wound fluid contains high levels of vascular endothelial growth factor, Ann Surg, 228, 707, 10.1097/00000658-199811000-00011 · DOI
  26. Altavilla, 2001, Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse, Diabetes, 50, 667, 10.2337/diabetes.50.3.667 · DOI · Paper page
  27. Goova, 2001, Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice, Am J Pathol, 159, 513, 10.1016/S0002-9440(10)61723-3 · DOI · Paper page
  28. Corral, 1999, Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing, Arch Surg, 134, 200, 10.1001/archsurg.134.2.200 · DOI
  29. Howdieshell, 2001, Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation, J Surg Res, 96, 173, 10.1006/jsre.2001.6089 · DOI · Paper page
  30. Lerman, 2003, Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia, Am J Pathol, 162, 303, 10.1016/S0002-9440(10)63821-7 · DOI · Paper page
  31. Drake, 2000, VEGF regulates cell behavior during vasculogenesis, Dev Biol, 224, 178, 10.1006/dbio.2000.9744 · DOI
  32. Cho, 2002, Developmental control of blood cell migration by the Drosophila VEGF pathway, Cell, 108, 865, 10.1016/S0092-8674(02)00676-1 · DOI · Paper page
  33. Damert, 2002, Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation, Development, 129, 1881, 10.1242/dev.129.8.1881 · DOI
  34. Shalaby, 1997, A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis, Cell, 89, 981, 10.1016/S0092-8674(00)80283-4 · DOI · Paper page
  35. Young, 2002, VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients, Proc Natl Acad Sci USA, 99, 11951, 10.1073/pnas.182215799 · doi:10.1073/pnas.182215799
  36. Pelosi, 2002, Identification of the hemangioblast in postnatal life, Blood, 100, 3203, 10.1182/blood-2002-05-1511 · DOI · Paper page
  37. Kalka, 2000, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization, Proc Natl Acad Sci USA, 97, 3422, 10.1073/pnas.97.7.3422 · DOI · Paper page
  38. Schatteman, 2000, Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice, J Clin Invest, 106, 571, 10.1172/JCI9087 · DOI · Paper page
  39. Carmeliet, 2001, The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis, Thromb Haemost, 86, 289, 10.1055/s-0037-1616226 · DOI
  40. Gerber, 2002, VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism, Nature, 417, 954, 10.1038/nature00821 · DOI · Paper page
  41. Bautz, 2000, Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment, Exp Hematol, 28, 700, 10.1016/S0301-472X(00)00168-5 · DOI
  42. Grant, 2002, Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization, Nat Med, 8, 607, 10.1038/nm0602-607 · DOI · Paper page
  43. Moore, 2002, Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing, J Cell Biochem Suppl, 38, 29, 10.1002/jcb.10105 · DOI
  44. Jo, 2000, Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1, J Clin Invest, 105, 101, 10.1172/JCI7954 · DOI · Paper page
  45. Shen, 2001, CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells, J Immunol, 166, 5027, 10.4049/jimmunol.166.8.5027 · DOI
  46. Petit, 2002, G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4, Nat Immunol, 3, 687, 10.1038/ni813 · DOI · Paper page
  47. Fedyk, 2001, Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing, J Immunol, 166, 5749, 10.4049/jimmunol.166.9.5749 · DOI
  48. Isner, 2001, VEGF gene transfer for diabetic neuropathy, Hum Gene Ther, 12, 1593
  49. Rivard, 1999, Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF, Am J Pathol, 154, 355, 10.1016/S0002-9440(10)65282-0 · DOI · Paper page
  50. Schratzberger, 2001, Reversal of experimental diabetic neuropathy by VEGF gene transfer, J Clin Invest, 107, 1083, 10.1172/JCI12188 · DOI · Paper page

Cited by

See all 798

Metadata

Authors
Galiano, R. D., Tepper, O. M., Pelo, C. R., Bhatt, K. A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H. G., & Gurtner, G. C.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2004-06
Volume
164
Issue
6
Pages
1935-1947
ISSN
0002-9440 (ISSN-L)
OpenAlex
W1989483643
Cited by
798
References
5
FWCI
20.44
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived Cells. https://app.cochat.ai/papers/10.1016/s0002-9440(10)63754-6
The paper
Galiano, R. D., Tepper, O. M., Pelo, C. R., Bhatt, K. A., Callaghan, M., Bastidas, N., Bunting, S., Steinmetz, H. G., & Gurtner, G. C. (2004). Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived Cells. The American Journal of Pathology. https://doi.org/10.1016/s0002-9440(10)63754-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.